TY - JOUR
T1 - Noaoxazole, a new heat shock metabolite produced by thermotolerant Streptomyces sp. HR41
AU - Saito, Shun
AU - Suzuki, Shiina
AU - Arai, Midori A.
N1 - Funding Information:
We thank Prof. Masaya Imoto at Juntendo University for providing actinomycete strains. This work was supported by the JSPS KAKENHI under Grant Number 20K15461 to SS.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to the Japan Antibiotics Research Association.
PY - 2022/9
Y1 - 2022/9
N2 - The thermotolerant strain Streptomyces sp. HR41 was found to produce compound 1 only in a 45 °C culture, and not at the standard temperature. We previously designated this type of compound as a “heat shock metabolite” (HSM). NMR and MS analytical techniques were used to determine that the chemical structure of 1 comprised a methylated-oxazole ring and a linear chain moiety modified with a terminal amide group. Thus, 1 was shown to be a new curromycin analog, which we have designated noaoxazole (1). Compound 1 weakly activated Notch signal reporter activity without exhibiting cytotoxicity against assay cells at the same concentration.
AB - The thermotolerant strain Streptomyces sp. HR41 was found to produce compound 1 only in a 45 °C culture, and not at the standard temperature. We previously designated this type of compound as a “heat shock metabolite” (HSM). NMR and MS analytical techniques were used to determine that the chemical structure of 1 comprised a methylated-oxazole ring and a linear chain moiety modified with a terminal amide group. Thus, 1 was shown to be a new curromycin analog, which we have designated noaoxazole (1). Compound 1 weakly activated Notch signal reporter activity without exhibiting cytotoxicity against assay cells at the same concentration.
UR - http://www.scopus.com/inward/record.url?scp=85135352918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135352918&partnerID=8YFLogxK
U2 - 10.1038/s41429-022-00551-5
DO - 10.1038/s41429-022-00551-5
M3 - Article
C2 - 35918479
AN - SCOPUS:85135352918
VL - 75
SP - 509
EP - 513
JO - Journal of Antibiotics
JF - Journal of Antibiotics
SN - 0021-8820
IS - 9
ER -